척추뼈 자극기 시장 : 기기 유형별, 최종 용도별, 세계 예측(2024-2032년)

Global Spine Bone Stimulators Market will witness over 5.7% CAGR between 2024 and 2032 due to increasing approvals and patents from leading companies. As spinal conditions continue to afflict a large segment of the population, innovative solutions are imperative for effective treatment.

For instance, in August 2022, Theragen, a medical device company, was delighted to announce the granting of a U.S. Patent recognizing its inventive strategy in creating the ActaStim-S Spine Fusion Bone Growth Stimulator system. Representing the first new Spine Fusion Stimulator in decades, ActaStim-S combined clinically validated therapeutic stimulation with contemporary design elements and a comprehensive digital health platform enriched with data.

Leading firms are investing extensively in research and development to bring novel bone stimulation technologies to market. These advancements enhance patient outcomes while addressing unmet medical needs in spine care. With regulatory approvals and patents driving market competitiveness, companies are poised to introduce a wide array of bone stimulators catering to diverse patient requirements. This surge in innovation underscores the pivotal role of research and development in shaping the future of the Spine Bone Stimulators Market.

The overall Spine Bone Stimulators Industry is classified based on the device type, end-use, and region.

The invasive spine bone stimulators segment will record significant growth from 2024 to 2032. These advanced medical devices are designed to stimulate bone growth and promote fusion in the spine through surgical implantation. As patients seek solutions for spinal conditions such as degenerative disc disease and spinal fractures, invasive spine bone stimulators offer a promising treatment option. Their ability to accelerate healing and improve spinal stability drives their popularity among healthcare providers and patients alike, fueling demand in the Spine Bone Stimulators Market.

Spine bone stimulators market share from the specialty clinics segment will register a noteworthy CAGR from 2024 to 2032. These clinics focus on providing specialized care for spinal conditions, including the use of bone stimulators to promote healing and fusion. As patients seek comprehensive treatment options tailored to their specific needs, specialty clinics offer expertise and personalized care in managing spinal disorders. Their emphasis on innovative therapies and patient-centric approaches contributes to the increased demand for spine bone stimulators, reflecting the growing importance of specialized healthcare services in addressing spine-related issues.

Europe spine bone stimulators market will showcase a commendable CAGR from 2024 to 2032. With a growing aging population and increasing prevalence of spinal disorders, there is a heightened demand for innovative treatment options. European healthcare systems prioritize access to advanced medical technologies, including spine bone stimulators, to improve patient outcomes. Additionally, the region's emphasis on research and development fosters the introduction of novel bone stimulation therapies, further driving market growth. As patients and healthcare providers seek effective solutions for spinal conditions, the demand for spine bone stimulators in Europe continues to rise, shaping the landscape of spine care.

For instance, in February 2022, A spinal cord stimulation study conducted by Dr. Jocelyne Bloch of Lausanne University Hospital and Gregoire Courtine of the Swiss Federal Institute of Technology yielded groundbreaking results. Published in the journal Nature Medicine on Monday, the STIMO clinical trial repurposed existing technology, originally aimed at pain relief, to specifically target spinal nerve roots, improving spine stimulation methods.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast parameters
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rise in incidence of spinal deformities
    • 3.2.1.2 Increasing demand for minimally invasive procedures
    • 3.2.1.3 Technological advancements in devices
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High device cost and lack of reimbursement rates
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Reimbursement scenario
• 3.7 Porter's analysis
  • 3.7.1 Supplier power
  • 3.7.2 Buyer power
  • 3.7.3 Threat of new entrants
  • 3.7.4 Threat of substitutes
  • 3.7.5 Industry rivalry
• 3.8 PESTEL analysis
• 3.9 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Invasive spine bone stimulators
• 5.3 Non-invasive spine bone stimulators
  • 5.3.1 Pulsed electromagnetic field devices
  • 5.3.2 Capacitive coupling (CC) devices
  • 5.3.3 Combined (electro) magnetic field (CMF) devices

Chapter 6 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Specialty clinics
• 6.4 Ambulatory surgical centers
• 6.5 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Italy
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
  • 7.4.6 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
  • 7.5.4 Rest of Latin America
• 7.6 Middle East and Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 South Africa
  • 7.6.3 UAE
  • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

• 8.1 Bioventus
• 8.2 Elizur Corporation
• 8.3 Enovis (DJO Global, Inc.)
• 8.4 IGEA S.p.A.
• 8.5 Medtronic plc
• 8.6 Orthofix Medical Inc.
• 8.7 Ossatec Benelux BV
• 8.8 Synergy Orthopedics
• 8.9 Theragen, Inc. (Neurotech NA Inc.)
• 8.10 ZimVie Inc